Related Experiment Video

Updated: Aug 23, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Oligonucleotide, antibody and peptide therapeutics--from design to the clinic

John Goodchild

    Current Opinion in Molecular Therapeutics
    |June 16, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
    08:09

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

    Published on: March 24, 2017

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
    07:36

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

    Published on: May 16, 2020

    Related Experiment Videos

    Last Updated: Aug 23, 2026

    Laboratory Scale Production and Purification of a Therapeutic Antibody
    09:54

    Laboratory Scale Production and Purification of a Therapeutic Antibody

    Published on: January 24, 2017

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
    08:09

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

    Published on: March 24, 2017

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
    07:36

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

    Published on: May 16, 2020

    Related Concept Videos

    Antibody Structure01:10

    Antibody Structure

    Overview
    Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
    The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
    Antibodies consist of four polypeptide chains: two identical heavy...
    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...

    Articles linked to this work by shared authors, journal, and citation graph.

    Therapeutic oligonucleotides.

    Methods in molecular biology (Clifton, N.J.)·2011

    Oligonucleotide therapeutics: 25 years agrowing.

    Current opinion in molecular therapeutics·2004

    Hammerhead ribozymes for target validation.

    Expert opinion on therapeutic targets·2002

    Gene therapy: Have the risks associated with viral vectors been solved?

    Current opinion in molecular therapeutics·2011

    Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

    Current opinion in molecular therapeutics·2010

    Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

    Current opinion in molecular therapeutics·2010

    Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

    Current opinion in molecular therapeutics·2010

    Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

    Current opinion in molecular therapeutics·2010

    Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

    Current opinion in molecular therapeutics·2010

    Medical Device Recalls in Neurosurgery: A United States Regulatory Analysis.

    Neurosurgery practice·2026

    Predictive biomarkers of biologic therapy response in chronic rhinosinusitis with nasal polyps: a systematic review.

    Frontiers in medicine·2026

    Llama mRNA-LNP immunization enables rapid isolation of target specific nanobodies using cell-based panning.

    Antibody therapeutics·2026

    An IgG-like fusion protein comprising an anti-spike S2 antibody and ACE2 exhibits potent and broad neutralization against SARS-CoV-2 and variants of concern.

    Antibody therapeutics·2026

    A landscape of sequence variants in 51 commercial antibody therapeutics.

    Antibody therapeutics·2026

    Evaluating plasma ferritin and suPAR as treatable traits for critically ill patients with COVID-19 treated with anakinra: an exploratory analysis of the immune modulation domain of the REMAP-CAP randomised clinical trial.

    Critical care (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us